Byun YR - Search Results

1

The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane.

Lee DK, Kim HS, Kim KS, Lee WJ, Kim HK, Won YH, Byun YR, Kim MY, Baik SK, Kwon SO. Lee DK, et al. Among authors: byun yr. Gastrointest Endosc. 2005 Feb;61(2):296-301. doi: 10.1016/s0016-5107(04)02570-2. Gastrointest Endosc. 2005. PMID: 15729251

2

The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.

Lee YK, Hyung Park J, Tae Moon H, Yun Lee D, Han Yun J, Byun Y. Lee YK, et al. Biomaterials. 2007 Mar;28(8):1523-30. doi: 10.1016/j.biomaterials.2006.11.020. Epub 2006 Dec 8. Biomaterials. 2007. PMID: 17157376

3

Improved blood compatibility by sustained release of heparin-deoxycholic acid conjugates in a PCL-PEG multiblock copolymer matrix.

Moon HT, Lee YK, Han JK, Byun Y. Moon HT, et al. J Biomater Sci Polym Ed. 2002;13(7):817-28. doi: 10.1163/156856202760197438. J Biomater Sci Polym Ed. 2002. PMID: 12296446

4

Functional and histological evaluation of transplanted pancreatic islets immunoprotected by PEGylation and cyclosporine for 1 year.

Yun Lee D, Hee Nam J, Byun Y. Yun Lee D, et al. Biomaterials. 2007 Apr;28(11):1957-66. doi: 10.1016/j.biomaterials.2006.12.015. Epub 2006 Dec 22. Biomaterials. 2007. PMID: 17188350

5

Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates.

Khatun Z, Nurunnabi, Cho KJ, Byun Y, Bae YH, Lee YK. Khatun Z, et al. J Control Release. 2014 Mar 10;177:64-73. doi: 10.1016/j.jconrel.2013.12.034. Epub 2014 Jan 9. J Control Release. 2014. PMID: 24412572

6

Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.

Lee YK, Kim SK, Lee DY, Lee S, Kim CY, Shin HC, Moon HT, Byun Y. Lee YK, et al. J Control Release. 2006 Apr 10;111(3):290-8. doi: 10.1016/j.jconrel.2005.12.011. Epub 2006 Feb 23. J Control Release. 2006. PMID: 16497407

7

Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.

Kim SK, Lee DY, Lee E, Lee YK, Kim CY, Moon HT, Byun Y. Kim SK, et al. J Control Release. 2007 Jul 16;120(1-2):4-10. doi: 10.1016/j.jconrel.2007.03.008. Epub 2007 Mar 20. J Control Release. 2007. PMID: 17490773

8

Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.

Kim SK, Lee EH, Vaishali B, Lee S, Lee YK, Kim CY, Moon HT, Byun Y. Kim SK, et al. J Control Release. 2005 Jun 20;105(1-2):32-42. doi: 10.1016/j.jconrel.2005.03.018. J Control Release. 2005. PMID: 15925422

9

Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation.

Kim SK, Vaishali B, Lee E, Lee S, Lee YK, Kumar TS, Moon HT, Byun Y. Kim SK, et al. Thromb Res. 2006;117(4):419-27. doi: 10.1016/j.thromres.2005.03.027. Thromb Res. 2006. PMID: 15913716

10

Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth.

Cho KJ, Moon HT, Park GE, Jeon OC, Byun Y, Lee YK. Cho KJ, et al. Bioconjug Chem. 2008 Jul;19(7):1346-51. doi: 10.1021/bc800173m. Epub 2008 Jun 28. Bioconjug Chem. 2008. PMID: 18588324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters